Educational Activities

Show Filters
Hide Filters
1-6 of 12 Activities
Title
Availability
Format
Credits
Course Opens
Buttons

2022 EGFR+ Lung Cancer Rapid Recap: The Evolving State of the Science in EGFR+ NSCLC—A Closer Look at the Paradigm-Shifting Synergy of Safety, Efficacy, and Equitable Access

This Rapid Recap will provide a responsive, timely, and incisive overview of data presented at the 2022 Clinical Oncology Annual Meeting, and offer expert insights into the shifting management landscape for metastatic EGFR+ NSCLC.

 

1.00
07/06/2022

Natasha B. Leighl

Thoracic Medical Oncology Group, Princess Margaret Cancer Centre
Professor, Department of Medicine
Adjunct Professor, Institute of Health Policy Management and Evaluation
University of Toronto, Toronto, ON, Canada

Natasha B. Leighl

Thoracic Medical Oncology Group, Princess Margaret Cancer Centre,
Professor, Department of Medicine,
Adjunct Professor, Institute of Health Policy Management and Evaluation,
University of Toronto, Toronto, ON, Canada

Helena Yu

Lung Cancer Medical Oncologist,
Memorial Sloan Kettering Cancer Center,
New York, NY

Helena Yu

Lung Cancer Medical Oncologist
Memorial Sloan Kettering Cancer Center
New York, NY

Jill Feldman

Lung Cancer Patient and Advocate
Chair, IASLC Patient Advocacy Committee
Co-Founder EGFR Resisters
Deerfield Park, IL

Jill Feldman

Lung Cancer Patient and Advocate
Chair, IASLC Patient Advocacy Committee
Co-Founder EGFR Resisters
Deerfield Park, IL

Breaking the Cycle in Cardiorenal Anemia Syndrome: The Practice-changing Role of IV Iron at the CKD–Heart Failure Interface

All clinicians managing patients with non-dialysis-dependent chronic kidney disease or heart failure must be aware of the deleterious impacts of concomitant anemia and the established, emerging, and practice-changing role of intravenous (IV) iron therapies.

1.0
08/15/2022

Javed Butler, MD, MPH, MBA

President, Baylor Scott and White Research Institute, Dallas, TX
Distinguished Professor of Medicine
University of Mississippi, Jackson, MS

Javed Butler, MD, MPH, MBA

President, Baylor Scott and White Research Institute, Dallas, TX
Distinguished Professor of Medicine
University of Mississippi, Jackson, MS

Matthew R. Weir, MD

Director, Division of Nephrology
Professor of Medicine
University of Maryland Medical System, Baltimore, MD

Matthew R. Weir, MD

Director, Division of Nephrology
Professor of Medicine
University of Maryland Medical System
Baltimore, MD

New Horizons in Unresectable Stage III NSCLC: A Case-based Exploration of Evolving Data and the Emergence of Immunotherapy

Join our Expert Faculty, Drs. Joel W. Neal, MD, PhD and Victoria Sherry, DNP, CRNP, AOCNP as they discuss treatment principles across the continuum of care in unresectable, stage III NSCLC.

1.0
09/23/2022

Joel W. Neal, MD, PhD

Associate Professor of Medicine, Division of Oncology
Medical Director for the Cancer Clinical Trials Office
Medical Director of Informatics Stanford Cancer Center Stanford, CA

Joel W. Neal, MD, PhD

Associate Professor of Medicine, Division of Oncology
Medical Director for the Cancer Clinical Trials Office
Medical Director of Informatics Stanford Cancer Center Stanford, CA

Victoria Sherry, DNP, CRNP, AOCNP

Oncology Nurse Practitioner for Thoracic Malignancies
Abramson Cancer Center
Philadelphia, PA

Victoria Sherry, DNP, CRNP, AOCNP

Oncology Nurse Practitioner for Thoracic Malignancies
Abramson Cancer Center
Philadelphia, PA

Navigating Novel Terrain in Anemia of Chronic Kidney Disease: A Patient-centric Review of Disease State, Current Chasms in Care, and the Future Promise of HIF-PH Inhibition

To facilitate timely diagnosis and rapid treatment initiation for anemia in CKD, the multidisciplinary and interprofessional CKD-anemia treatment team should be aware of the significant impact of anemia on patient quality of life, progression of CKD, and cardiovascular events.

1.0
11/01/2022

Calvin J. Meaney, PharmD, BCPS

Clinical Associate Professor and Vice Chair for Research
Department of Pharmacy Practice
School of Pharmacy and Pharmaceutical Sciences
University at Buffalo, Buffalo, NY

Calvin J. Meaney, PharmD, BCPS

Clinical Associate Professor and Vice Chair for Research
Department of Pharmacy Practice
School of Pharmacy and Pharmaceutical Sciences
University at Buffalo, Buffalo, NY

Jane S. Davis, DNP, CRNP

Nephrology
University of Alabama at Birmingham
Birmingham, AL

Jane S. Davis, DNP, CRNP

Nephrology
University of Alabama at Birmingham
Birmingham, AL

Ajay K. Singh, MBBS, FRCP, MBA

Senior Associate Dean for Postgraduate Medical Education
Director, Master in Medical Sciences in Clinical Investigation (MMSCI) program, Harvard Medical School
Physician, Renal Division
Brigham and Women's Hospital/ Dana Farber Cancer Institute, Boston, MA

Ajay K. Singh, MBBS, FRCP, MBA

Senior Associate Dean for Postgraduate Medical Education
Director, Master in Medical Sciences in Clinical Investigation (MMSCI) program, Harvard Medical School
Physician, Renal Division
Brigham and Women’s Hospital/ Dana Farber Cancer Institute, Boston, MA

Pulmonology Perspectives on Biomarker Testing in NSCLC: Multidisciplinary Management in an Era of Rapid Change

This dynamic live symposium, led by top experts in the field of pulmonary medicine and NSCLC, will take attendees on a deep dive into the sentinel role of the pulmonologist in the NSCLC management paradigm, exploring adaptive mechanisms to optimize collaborative strategies in a patient centric manner.

2.0
11/21/2022

Jill Feldman

Lung Cancer Patient and Advocate
Chair, IASLC Patient Advocacy Committee
Co-Founder EGFR Resisters
Deerfield Park, IL

Jill Feldman

Lung Cancer Patient and Advocate
Chair, IASLC Patient Advocacy Committee
Co-Founder EGFR Resisters
Deerfield Park, IL

Raymond U. Osarogiagbon, MD

Director, Multidisciplinary Thoracic Oncology Program

Raymond U. Osarogiagbon, MD

Director, Multidisciplinary Thoracic Oncology Program

Gerard A. Silvestri, MD, MS

George C. and Margaret M. Hillenbrand Endowed Chair
Professor, Division of Pulmonary, Critical Care, Allergy and Sleep Medicine
Medical University of South Carolina, Charleston

Gerard A. Silvestri, MD, MS

George C. and Margaret M. Hillenbrand Endowed Chair
Professor, Division of Pulmonary, Critical Care, Allergy and Sleep Medicine
Medical University of South Carolina, Charleston

Hiren Mehta, MD

Medical Director, UF Shands Medical Intensive Care Unit
Division Vice-Chief for Medical Affairs
Program Director, Interventional Pulmonology Fellowship Program
University of Florida Health, Gainesville, FL

Hiren Mehta, MD

Medical Director, UF Shands Medical Intensive Care Unit
Division Vice-Chief for Medical Affairs
Program Director, Interventional Pulmonology Fellowship Program
University of Florida Health, Gainesville, FL

Lynette M. Sholl, MD

Harvard Medical School
Brigham and Women's Hospital
Boston, MA

Lynette M. Sholl, MD

Harvard Medical School
Brigham and Women’s Hospital
Boston, MA